ALDEYRA THERAPEUTICS INC's ticker is ALDX and the CUSIP is 01438T106. A total of 91 filers reported holding ALDEYRA THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 2.46 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $405 | +195.6% | 60,649 | +339.5% | 0.00% | +300.0% |
| Q1 2023 | $137 | -99.9% | 13,800 | -59.0% | 0.00% | -50.0% |
| Q3 2022 | $180,000 | +100.0% | 33,685 | +49.7% | 0.00% | +100.0% |
| Q2 2022 | $90,000 | +1.1% | 22,495 | +11.7% | 0.00% | 0.0% |
| Q1 2022 | $89,000 | -11.0% | 20,131 | -19.6% | 0.00% | 0.0% |
| Q4 2021 | $100,000 | -62.7% | 25,031 | -17.9% | 0.00% | -75.0% |
| Q3 2021 | $268,000 | -85.6% | 30,494 | -80.5% | 0.00% | -85.2% |
| Q1 2021 | $1,858,000 | +94.1% | 156,414 | +12.1% | 0.03% | +200.0% |
| Q4 2020 | $957,000 | +1025.9% | 139,520 | +1121.5% | 0.01% | +350.0% |
| Q3 2020 | $85,000 | +54.5% | 11,422 | -12.7% | 0.00% | +100.0% |
| Q2 2020 | $55,000 | – | 13,085 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 908,488 | $6,232,000 | 2.88% |
| Knoll Capital Management, LLC | 569,405 | $3,906,000 | 2.66% |
| Mesirow Financial Investment Management, Inc. | 64,698 | $443,828,000 | 1.40% |
| Ghost Tree Capital, LLC | 650,000 | $4,459,000 | 0.99% |
| Johnson & Johnson Innovation - JJDC, Inc. | 594,834 | $4,081,000 | 0.53% |
| Perceptive Advisors | 6,285,458 | $43,118,000 | 0.46% |
| Affinity Asset Advisors, LLC | 100,000 | $686,000 | 0.36% |
| ACUTA CAPITAL PARTNERS, LLC | 192,500 | $1,321,000 | 0.36% |
| Avidity Partners Management LP | 1,435,000 | $9,844,000 | 0.32% |
| APOGEM CAPITAL LLC | 55,821 | $383,000 | 0.26% |